Falko Fend

Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 348 publications

Title Not Found

Title Not Found

Journal: Pathologie (Heidelberg, Germany)

Published: May 19, 2026

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Journal: Human pathology

Published: May 11, 2026

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

Journal: Blood

Published: February 11, 2026

DECODE VRL Report No. 1: Lymphocyte Survival After Diagnostic Vitrectomy - Does Size Matter?

DECODE VRL Report No. 1: Lymphocyte Survival After Diagnostic Vitrectomy - Does Size Matter?

Journal: Translational vision science & technology

Published: January 27, 2026

Sweet stuff is dangerous in DLBCL.

Sweet stuff is dangerous in DLBCL.

Journal: Blood

Published: December 04, 2025

The genetic landscape of extramedullary plasmacytoma: a comparative analysis with extramedullary disease of multiple myeloma.

The genetic landscape of extramedullary plasmacytoma: a comparative analysis with extramedullary disease of multiple myeloma.

Journal: Haematologica

Published: November 10, 2025

Authors' reply: Re: Yang et al. The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK/ERK mutations and clonal evolution.

Authors' reply: Re: Yang et al. The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK/ERK mutations and clonal evolution.

Journal: The journal of pathology. Clinical research

Published: November 06, 2025

Diagnostic challenges in pediatric lymphomas

Diagnostic challenges in pediatric lymphomas

Journal: Pathologie (Heidelberg, Germany)

Published: October 31, 2025

DNA methylation-based classification of hematolymphoid neoplasms.

DNA methylation-based classification of hematolymphoid neoplasms.

Journal: Blood advances

Published: October 20, 2025

Immune disparities in the TME of EBV+ and EBV- BL: role of reactive oxygen species generation pathways and platelet activation.

Immune disparities in the TME of EBV+ and EBV- BL: role of reactive oxygen species generation pathways and platelet activation.

Journal: Blood advances

Published: September 24, 2025

Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC.

Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC.

Journal: Pharmacological research

Published: September 23, 2025

CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

Journal: Leukemia

Published: August 12, 2025

Showing 1-12 of 348

Last Updated: 09/26/2026